The global thrombopoietin receptor market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The TPO receptor is found in a wide range of hematopoietic cells such as mature megakaryocytes and platelets, immature cells of all lineages, CD34+ cells, and pluripotential stem cells. They affect all aspects of platelet production that ranges from self-renewal and expansion of hematopoietic stem cells (HSCs) to stimulation of the proliferation of megakaryocyte progenitor cells as well as to support the maturation of these cells into platelet-producing cells.
The major factor contributing to the growth of the global thrombopoietin receptor market include the new FDA approvals. For instance, in June 2019, Dova Pharmaceuticals, Inc. announced the approval of a supplemental New Drug Application (sNDA) that expands the use of DOPTELET (avatrombopag) by the US Food and Drug Administration (FDA). It is used for the treatment of thrombocytopenia in adults with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment.
To Request a Sample of our Report on Thrombopoietin Receptor Market: https://www.omrglobal.com/request-sample/thrombopoietin-receptor-market
Some major players operating in the market include Amgen Inc., Novartis International AG, and GlaxoSmithKline plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies, including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2019, Swedish Orphan Biovitrum AB announced the completion of the acquisition of Dova Pharmaceuticals, Inc. With the acquisition, Sobi received the rights for Doptelet, a drug used in chemotherapy-induced thrombocytopenia.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Amgen Inc., Novartis International AG, and GlaxoSmithKline plc, among others.
(Get 15% Discount on Buying this Report)
A full Report of Thrombopoietin Receptor Market is Available @ https://www.omrglobal.com/industry-reports/thrombopoietin-receptor-market
Global Thrombopoietin Receptor Market Report by Segment
By Type
- Eltrombopag Olamine
- GSK-2285921
- Romiplostim
- STST-4
- Others
By Application
- Clinic
- Hospital
- Others
Global Thrombopoietin Receptor Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
